HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early Protection by Resveratrol in Rat Lung Transplantation.

Abstract
BACKGROUND Resveratrol is a multifunctional bioactive substance that has effects in anti-inflammation and prevention of ischemia-reperfusion injury. This study compared the inflammation and expression of related proteins during the early stages after transplantation to explore the effects and mechanisms of resveratrol on transplanted lung. MATERIAL AND METHODS Sprague-Dawley rats were randomized to receive pretreatment of resveratrol suspension (60 mg/kg; RES group), dexamethasone (1 mg/kg; DEM group), or normal saline solution (2 mL/kg; control group) 1 h before lung transplantation. The cytokine concentration in the serum and bronchoalveolar lavage fluid (BALF) of the recipients was determined 24 h after transplantation. Histopathologic evaluation, including lung injury score, and the expression of necroptosis-associated proteins was assessed. RESULTS Histopathologic evaluation showed pneumocyte damage and endothelialitis associated with hemorrhage in the alveoli in the control group, the severity of which was greater than that in the other 2 groups. The levels of interleukin-6 and tumor necrosis factor-a in the serum and BALF of the RES and DEM groups were lower than those in the control group. The expression of necroptosis-associated proteins in the RES group was lower than that in the control group, and was inversely proportional to lung injury. CONCLUSIONS Pretreatment with resveratrol protected rat lung in the early stages after transplantation. We determined a relationship between necroptosis-associated proteins and transplanted lung injury, which suggests that the mechanism of lung transplantation-associated ischemia-reperfusion injury may be related to necroptosis.
AuthorsHai-Chao Xu, Wang Lv, Lu-Ming Wang, Peng Ye, Jian Hu
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) Vol. 25 Pg. 760-770 (Jan 26 2019) ISSN: 1643-3750 [Electronic] United States
PMID30684444 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Resveratrol
Topics
  • Acute Lung Injury (pathology)
  • Animals
  • Apoptosis (drug effects)
  • Bronchoalveolar Lavage Fluid (cytology)
  • Cytokines (analysis, blood)
  • Dexamethasone (pharmacology)
  • Inflammation (drug therapy, pathology)
  • Interleukin-6 (analysis)
  • Lung (pathology)
  • Lung Transplantation (methods)
  • Male
  • Pulmonary Alveoli (pathology)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (pathology)
  • Resveratrol (metabolism, pharmacology)
  • Tumor Necrosis Factor-alpha (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: